BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2174735)

  • 21. Herpes simplex virus type 2 and pseudorabies virus associated growth factors and their role in the latency in vitro.
    Golais F; Csabayová M; Lesko J; Bystrická M; Sabó A
    Acta Virol; 1992 Dec; 36(6):505-15. PubMed ID: 1284865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human natural killer cells limit replication of herpes simplex virus type 1 in vitro.
    Fitzgerald PA; Mendelsohn M; Lopez C
    J Immunol; 1985 Apr; 134(4):2666-72. PubMed ID: 2982949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
    Colmenares C; Lopez C
    J Immunol; 1986 May; 136(9):3473-80. PubMed ID: 2420891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The development of an improved murine iontophoresis reactivation model for the study of HSV-1 latency.
    Gordon YJ; Araullo-Cruz TP; Romanowski E; Ruziczka L; Balouris C; Oren J; Cheng KP; Kim S
    Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1230-4. PubMed ID: 3015823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intradermal doxorubicin reduces ganglionic reactivation of latent herpes simplex virus in mice after pretreatment with hypertonic saline.
    Sekizawa T; Openshaw H; Itoyama Y
    J Med Virol; 2003 Jun; 70(2):263-6. PubMed ID: 12696114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Herpes simplex virus infection of in vitro cultured neuronal cells (mouse neuroblastoma C 1300 cells).
    Vahlne A; Lycke E
    J Gen Virol; 1978 May; 39(2):321-32. PubMed ID: 206658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of a potent refractory state and persistence of herpes simplex virus 1 in cell culture.
    Barreca C; O'Hare P
    J Virol; 2006 Sep; 80(18):9171-80. PubMed ID: 16940528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytodifferentiating agents affect the replication of herpes simplex virus type 1 in the absence of functional VP16.
    Preston CM; McFarlane M
    Virology; 1998 Sep; 249(2):418-26. PubMed ID: 9791032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recovery of herpes simplex virus from ocular tissues of latently infected inbred mice.
    Abghari SZ; Stulting RD
    Invest Ophthalmol Vis Sci; 1988 Feb; 29(2):239-43. PubMed ID: 2828265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reproduction in unadapted and adapted cells at 40 degrees C of herpes simplex virus type 1 and type 2 strains.
    Szántó J
    Acta Virol; 1975 Jul; 19(4):287-92. PubMed ID: 241225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Replication of type I herpes simplex virus in primary cultures of hairy cell leukemic leukocytes.
    Pozner LH; Daniels CA; Cooper JA; Cohen HJ; Logue GL; Croker BP
    Am J Pathol; 1978 Jan; 90(1):187-200. PubMed ID: 202167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishment of herpes simplex virus latency in vitro with cycloheximide.
    Shiraki K; Rapp F
    J Gen Virol; 1986 Nov; 67 ( Pt 11)():2497-500. PubMed ID: 3023534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Herpes simplex virus latency in a hyperresistant clone of mouse neuroblastoma (Cl300) cells.
    Nilheden E; Jeansson S; Vahlne A
    Arch Virol; 1985; 83(3-4):319-25. PubMed ID: 2982359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of human leukocyte interferon on IgG on the replication of herpes simplex virus in nervous tissue in vitro.
    Bal E; Puricelli L; de la Peña NC; de Lustig ES
    Acta Virol; 1979 Nov; 23(6):461-7. PubMed ID: 94767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Latency in vitro using irradiated herpes simplex virus.
    Nishiyama Y; Rapp F
    J Gen Virol; 1981 Jan; 52(Pt 1):113-9. PubMed ID: 6267167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential susceptibility of a rat glioma cell line and its clones to herpes simplex virus types 1 and 2.
    Sakihama K; Eizuru Y; Minamishima Y
    Acta Virol; 1991 Apr; 35(2):127-34. PubMed ID: 1681710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced in vitro reactivation of herpes simplex virus type 2 from latently infected guinea-pig neural tissues by 5-azacytidine.
    Stephanopoulos DE; Kappes JC; Bernstein DI
    J Gen Virol; 1988 May; 69 ( Pt 5)():1079-83. PubMed ID: 2453606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishment of latency in vitro by the herpes simplex virus type 1 mutant in1814.
    Harris RA; Preston CM
    J Gen Virol; 1991 Apr; 72 ( Pt 4)():907-13. PubMed ID: 1849973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro reactivation of latent herpes simplex virus by the demethylating compound hexamethylene-bis-acetamide.
    Blondeau JM; Aoki FY
    J Virol Methods; 1992 Dec; 40(3):323-9. PubMed ID: 1335458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased susceptibility to infection with herpes simplex virus types 1 and 2 of cold-adapted L cells.
    Szántó J; Holecková E
    Acta Virol; 1978 Mar; 22(2):113-22. PubMed ID: 26196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.